Remedi (Diagnostic Equipment) Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
7
- Stock Symbol
-
387690
- Share Price
-
$7.58
- (As of Friday Closing)
Remedi (Diagnostic Equipment) General Information
Description
Remedi Inc develops, manufactures, and sells portable X-ray imaging devices and industrial non-destructive testing (NDT) equipment. Its products are based on proprietary thermionic X-ray tube, high-voltage power supply, and compact X-ray generation and control technologies. The company's products are used in medical, dental, veterinary, and industrial applications.
Contact Information
Website
www.remedihc.comCorporate Office
- 2 Floor, 69-14 Sakju-ro 145 beon-gil
- Chuncheon, Gangwon 24232
- South Korea
Corporate Office
- 2 Floor, 69-14 Sakju-ro 145 beon-gil
- Chuncheon, Gangwon 24232
- South Korea
Remedi (Diagnostic Equipment) Stock Performance
As of 13-Nov-2026, Remedi (Diagnostic Equipment)’s stock price is $7.58. Its current market cap is $57.8M with 7.63M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.58 | $7.73 | $4.80 - $23.09 | $57.8M | 7.63M | 1.56M | $0.97 |
Remedi (Diagnostic Equipment) Financials Summary
As of 30-Jun-2026, Remedi (Diagnostic Equipment) has a trailing 12-month revenue of $15.7M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| Revenue | 15,690 | 10,279 | 9,851 | 5,291 |
| EBITDA | 5,866 | 2,235 | 1,083 | (1,975) |
| Net Income | 6,216 | 3,489 | 664 | (2,799) |
| Total Assets | 21,019 | 19,847 | 11,451 | 13,150 |
| Total Debt | 7,246 | 8,263 | 6,121 | 8,059 |
Remedi (Diagnostic Equipment) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Remedi (Diagnostic Equipment) Patents
Remedi (Diagnostic Equipment) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260256670-A1 | Composition containing peptides having skin-lightening effect | Pending | 31-Aug-2022 | ||
| WO-2024048890-A1 | Composition containing peptides having skin-lightening effect | Inactive | 31-Aug-2022 | ||
| EP-4583145-A1 | Filament production method, filament produced thereby, and x-ray tube comprising same | Pending | 29-Aug-2022 | ||
| WO-2024048843-A1 | Filament production method, filament produced thereby, and x-ray tube comprising same | Inactive | 29-Aug-2022 | ||
| US-12444565-B2 | Method of manufacturing a filament, filament manufactured thereby, and x-ray tube having the filament | Active | 29-Aug-2022 | H01J9/02 |
Remedi (Diagnostic Equipment) Signals
Remedi (Diagnostic Equipment) FAQs
-
When was Remedi (Diagnostic Equipment) founded?
Remedi (Diagnostic Equipment) was founded in 2012.
-
Where is Remedi (Diagnostic Equipment) headquartered?
Remedi (Diagnostic Equipment) is headquartered in Chuncheon, South Korea.
-
What is the size of Remedi (Diagnostic Equipment)?
Remedi (Diagnostic Equipment) has 7 total employees.
-
What industry is Remedi (Diagnostic Equipment) in?
Remedi (Diagnostic Equipment)’s primary industry is Diagnostic Equipment.
-
Is Remedi (Diagnostic Equipment) a private or public company?
Remedi (Diagnostic Equipment) is a Public company.
-
What is Remedi (Diagnostic Equipment)’s stock symbol?
The ticker symbol for Remedi (Diagnostic Equipment) is 387690.
-
What is the current stock price of Remedi (Diagnostic Equipment)?
As of 13-Nov-2026 the stock price of Remedi (Diagnostic Equipment) is $7.58.
-
What is the current market cap of Remedi (Diagnostic Equipment)?
The current market capitalization of Remedi (Diagnostic Equipment) is $57.8M.
-
What is Remedi (Diagnostic Equipment)’s current revenue?
The trailing twelve month revenue for Remedi (Diagnostic Equipment) is $15.7M.
-
What is Remedi (Diagnostic Equipment)’s annual earnings per share (EPS)?
Remedi (Diagnostic Equipment)’s EPS for 12 months was $0.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process